Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

Clinical trial NCT07711327 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07711327
Sponsor: Tina Baykaner
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Atrial Fibrillation (AF)Chronic Lymphocytic Leukemia Waldenstrom Macroglobulinemia Mantle Cell Lymphoma Marginal Zone Lymphoma

Start date: 2026-08-01
Primary completion: 2031-08-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.